$MLYS

$21.38▲ +1.2% YTD

13 SEC 13D/G filings tracked · Last updated Oct 28, 2026

Filing History

MLYS ▲ +1.2% - Mineralys Therapeutics, Inc.

CP $21.38▲ +1.2%Oct 28, 2026 · ThinkSabio Blog

$MLYS - Mineralys Therapeutics to Announce Third Quarter 2026 Financial Results and Host Conference Call on Wednesday, November 4, 2026…

News

MLYS ▲ +7.4% - Mineralys Therapeutics, Inc.

CP $22.69▲ +7.4%Oct 28, 2026 · ThinkSabio Blog

$MLYS some vol pm MLYS Mineralys Therapeutics Announces Publication of Phase 2 Explore-CKD Trial Results for Lorundrostat in Kidney International - Ex…

News

MLYS ▲ +0.8% - Mineralys Therapeutics, Inc.

CP $21.30▲ +0.8%Oct 28, 2026 · ThinkSabio Blog

$MLYS - Mineralys Therapeutics Announces Publication of Phase 2 Explore-CKD Trial Results for Lorundrostat in Kidney International…

News

MLYS ▲ +1.8% - Mineralys Therapeutics, Inc.

CP $21.47▲ +1.8%Oct 22, 2026 · ThinkSabio Blog

$MLYS - Mineralys Therapeutics Presents New Lorundrostat Data in Participants with Hypertension and Chronic Kidney Disease at ASN Kidney Week 2026…

News

MLYS ▲ +3.1% - Mineralys Therapeutics, Inc.

CP $20.92▲ +3.1%Oct 19, 2026 · ThinkSabio Blog

$MLYS - Mineralys Therapeutics Expands its Board of Directors with the Appointments of Kristine Peterson and Lonnel Coats…

News

MLYS ▼ -0.1% - Mineralys Therapeutics, Inc.

CP $22.35▲ -0.1%Oct 9, 2026 · ThinkSabio Blog

$MLYS - Mineralys Therapeutics Presents New Data for Lorundrostat at the American Heart Association Hypertension Scientific Sessions 2026…

News

MLYS ▼ -0.4% - Mineralys Therapeutics, Inc.

CP $23.63▲ -0.4%Oct 2, 2026 · ThinkSabio Blog

$MLYS - Mineralys Therapeutics Announces Presentation of New Lorundrostat Data at the American Society of Nephrology (ASN) Kidney Week 2026…

News

MLYS ▼ -5.6% - Mineralys Therapeutics, Inc.

CP $23.72▲ -5.6%Oct 1, 2026 · ThinkSabio Blog

$MLYS - Mineralys Therapeutics Announces Presentation of Lorundrostat Data at American Heart Association Hypertension Scientific Sessions 2026…

News

MLYS ▼ -4.5% - Mineralys Therapeutics, Inc.

CP $24.48▲ -4.5%Sep 29, 2026 · ThinkSabio Blog

$MLYS - Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)…

News

MLYS ▼ -1.0% - Mineralys Therapeutics, Inc.

CP $26.59▲ -1.0%Sep 24, 2026 · ThinkSabio Blog

$MLYS - Mineralys Therapeutics to Participate in the Stifel 2026 Virtual Cardiometabolic Forum…

News

MLYS ▼ -7.2% - Mineralys Therapeutics, Inc.

CP $27.28▲ -7.2%Sep 23, 2026 · ThinkSabio Blog

$MLYS - Mineralys Therapeutics’ Transform-HTN Open-Label Extension Trial Data Selected for Late-Breaking Presentation at American Heart Association Sc…

News

MLYS ▼ -2.0% - Mineralys Therapeutics, Inc.

CP $30.50▲ -2.0%Sep 9, 2026 · ThinkSabio Blog

$MLYS - Mineralys Therapeutics Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)…

SEC 13D/G

MLYS - Mineralys Therapeutics, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$27.03▼ -24.24%Aug 6, 2026 · ThinkSabio Blog

$MLYS SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #MLYS Mineralys Therapeutics, Inc. : $27.03 Sector: Healthcare |…